Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen
This study has been completed.
First Posted: August 31, 2001
Last Update Posted: December 9, 2005
Information provided by:
NIH AIDS Clinical Trials Information Service